ymbio6k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2012
Commission File Number: 1-32186
|
YM BIOSCIENCES INC.
(Translation of registrant's name into English)
|
| |
|
Suite 400, Building 11
5045 Orbiter Drive
Mississauga, Ontario
Canada L4W 4Y4
(Address of principal executive offices)
|
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) o
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
YM BIOSCIENCES INC.
|
| |
|
| |
|
| |
By:
|
/s/ Leonard Vernon
|
| |
|
Leonard Vernon
Vice President, Finance and Administration
|
Date: November 9, 2012
EXHIBIT INDEX
|
Exhibit
|
|
Description
|
| |
|
|
|
99.1
|
|
News Release Dated November 9, 2012 - YM BioSciences Reports Operational and Financial Results for the First Quarter of Fiscal 2013
|